Nardostachys chinensis induces granulocytic differentiation with the suppression of cell growth through p27^Kip1 protein-related G₀/G₁ phase arrest in human promyelocytic leukemic cells

References

• Aksentijevich I, Flinm IW. (2003). Chronic lymphocytic leukemia: Advances in biology and therapeutics. Curr Opin Oncol 15:16–22
   PubMed Web of Science ®Google Scholar
• Baj G, Arnulfo A, Deaglio S, et al. (2000). Retinoids in breast cancer prevention and treatment. A review of the literature. Eur J Gynaecol Oncol 21:411–15
   PubMed Web of Science ®Google Scholar
• Breitman TR, Selonick SE, Collins SJ. (1980). Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936–40
   PubMed Web of Science ®Google Scholar
• Brugarolas J, Chandrasekaran C, Gordon JI, et al. (1995). Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552–7
   PubMed Web of Science ®Google Scholar
• Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. (1978). Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci USA 75:2458–62
   PubMed Web of Science ®Google Scholar
• Cooper S. (2001). Revisiting the relationship of the mammalian G1 phase to cell differentiation. J Theor Biol 208:399–402
   PubMed Web of Science ®Google Scholar
• Covacci V, Bruzzese N, Sgambato A, et al. (1998). Magnesium restriction induces granulocytic differentiation and expression of p27Kip1 in human leukemic HL-60 cells. J Cell Biochem 70:313–22
   PubMed Web of Science ®Google Scholar
• Dimberg A, Oberg F. (2003). Retinoic acid-induced cell cycle arrest of human myeloid cell lines. Leuk Lymphoma 44:1641–50
   PubMed Web of Science ®Google Scholar
• el-Deiry WS, Harper JW, O'Connor PM, et al. (1994). WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169–74
   PubMed Web of Science ®Google Scholar
• Elledge SJ, Harper JW. (1994). Cdk inhibitors: On the threshold of checkpoints and development. Curr Opin Cell Biol 6:847–52
   PubMed Web of Science ®Google Scholar
• Furukawa Y, Uenoyama S, Ohta M, et al. (1992). Transforming growth factor-beta inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I. J Biol Chem 267:17121–7
   PubMed Web of Science ®Google Scholar
• Gezer S, Yasin Z, Imren S, et al. (1988). Changes observed in the growth fraction, labeling index, duration of S phase, and total cell cycle times of HL-60 cells as they undergo differentiation in response to retinoic acid. Cancer Res 48:5989–94
   PubMed Web of Science ®Google Scholar
• Harvat BL, Seth P, Jetten AM. (1997). The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells. Oncogene 14:2111–22
   PubMed Web of Science ®Google Scholar
• Huberman E, Callaham MF. (1979). Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc Natl Acad Sci USA 76:1293–7
   PubMed Web of Science ®Google Scholar
• Hui EK, Yung BY. (1993). Cell cycle phase-dependent effect of retinoic acid on the induction of granulocytic differentiation in HL-60 promyelocytic leukemia cells. Evidence for sphinganine potentiation of retinoic acid-induced differentiation. FEBS Lett 318:193–9
   PubMed Web of Science ®Google Scholar
• Itokawa H, Masuyama K, Morita H, Takeya K. (1993). Cytotoxic sesquiterpenes from Nardostachys chinensis. Chem Pharm Bull (Tokyo) 41:1183–4
   PubMed Web of Science ®Google Scholar
• Li P, Matsunaga K, Yamakuni T, Ohizumi Y. (2003). Nardosinone, the first enhancer of neurite outgrowth-promoting activity of staurosporine and dibutyryl cyclic AMP in PC12D cells. Brain Res Dev Brain Res 145:177–83
   PubMedGoogle Scholar
• Lo Coco F, Zelent A, Kimchi A, et al. (2002). Progress in differentiation induction as a treatment for acute promyelocytic leukemia and beyond. Cancer Res 62:5618–21
   PubMed Web of Science ®Google Scholar
• Myers CE. (1999). Differentiating agents and nontoxic therapies. Urol Clin North Am 26:341–51
   PubMed Web of Science ®Google Scholar
• Parmar S, Tallman MS. (2003). Acute promyelocytic leukemia: A review. Exp Opin Pharmacother 4:1379–92
   PubMed Web of Science ®Google Scholar
• Patnaik A, Rowinsky EK, Villalona MA, et al. (2002). A phase I study of pivaloyloxymethylbutyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies. Clin Cancer Res 8:2142–8
   PubMed Web of Science ®Google Scholar
• Peter M, Herskowitz I. (1994). Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79:181–4
   PubMed Web of Science ®Google Scholar
• Rovera G, Santoli D, Damsky C. (1979). Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci USA 76:2779–83
   PubMed Web of Science ®Google Scholar
• Sakashita A, Nakamaki T, Tsuruoka N, et al. (1991). Granulocyte colony-stimulating factor, not granulocyte-macrophage colony-stimulating factor, co-operates with retinoic acid on the induction of functional N-formyl-methionyl-phenylalanine receptors in HL-60 cells. Leukemia 5:26–31
   PubMed Web of Science ®Google Scholar
• Sciarra A, Casale P, Di Chirio C, et al. (1998). New aspects on prostate cancer: Hereditary form, developmental estrogenization and differentiation therapy. Minerva Urol Nefrol 50:185–90
   PubMedGoogle Scholar
• Seo BI, Lee JH, Choi HY, et al. (2008). Korean Medicine Herbology. Seoul: Younglim Press, 496–7
   Google Scholar
• Seo BR, Lee KW, Ha J, et al. (2004). Saucernetin-7 isolated from Saururus chinensis inhibits proliferation of human promyelocytic HL-60 leukemia cells via G0/G1 phase arrest and induction of differentiation. Carcinogenesis 25:1387–94
   PubMed Web of Science ®Google Scholar
• Sheaff RJ, Groudine M, Gordon M, et al. (1997). Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 11:1464–78
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149–63
   PubMed Web of Science ®Google Scholar
• Spira AI, Carducci MA. (2003). Differentiation therapy. Curr Opin Pharmacol 3:338–43
   PubMed Web of Science ®Google Scholar
• Takaya Y, Takeuji Y, Akasaka M, et al. (2000). Novel guaiane endoperoxides, nardoguaianone A–D, from roots and their antinociceptive and antimalarial activities. Tetrahedron 56:7673–8
   Web of Science ®Google Scholar
• Walczak J, Wood H, Wilding G, et al. (2001). Prostate cancer prevention strategies using antiproliferative or differentiating agents. Urology 57:81–5
   PubMed Web of Science ®Google Scholar
• Wang QM, Jones JB, Studzinski GP. (1996). Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res 56:264–7
   PubMed Web of Science ®Google Scholar
• Wang Z, Sun G, Shen Z, et al. (1999). Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application. Chin Med J (Engl) 112:963–7
   PubMed Web of Science ®Google Scholar
• Xiao PG. (2002). Modern Chinese Materia Medica. Beijing: Chemical Industry Press, 252–3
   Google Scholar
• Xiong Y, Hannon GJ, Zhang H, et al. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366:701–4
   PubMed Web of Science ®Google Scholar
• Yang Q, Sakurai T, Kakudo K. (2002). Retinoid, retinoic acid receptor beta and breast cancer. Breast Cancer Res Treat 76:167–73
   PubMed Web of Science ®Google Scholar